IL10 and stroke disorder: IL-10 overexpressing animals showed reduced short-term infarct volumes and apoptosis after pMCAO [59, 179], while exogenous administration of IL-10 demonstrated therapeutic potentials by limiting post-stroke inflammation [147, 175, 216].